Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Turkey

Industry Negotiations See Minor Improvements To Negative Price Revisions

December 2009 | Industry Trend Analysis

BMI's prediction about the outcome of Turkey's pricing revisions has proved correct. Upon delaying the implementation of new legislation in November 2009, we noted that the pricing decree would be challenging to overturn, although further evaluation of the changes was a serious possibility.[1] This has indeed been the case, with the country's new pricing scheme, implemented on December 4 2009, providing small, albeit beneficial outcomes for the pharmaceutical

To read the full article, please choose one of the following options:

Subcribers please log in

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries